KAMRAN AHRAR to Carcinoma, Renal Cell
This is a "connection" page, showing publications KAMRAN AHRAR has written about Carcinoma, Renal Cell.
Connection Strength
2.085
-
Outcomes of Percutaneous Thermal Ablation for Biopsy-Proven T1a Renal Cell Carcinoma in Patients With Other Primary Malignancies. AJR Am J Roentgenol. 2021 07; 217(1):157-163.
Score: 0.331
-
Ablation of Small Renal Masses. Tech Vasc Interv Radiol. 2020 Jun; 23(2):100674.
Score: 0.310
-
Chyluria after radiofrequency ablation of renal tumors. J Vasc Interv Radiol. 2011 Jul; 22(7):924-7.
Score: 0.165
-
Nephron-sparing probe ablative therapy: long-term outcomes. Curr Opin Urol. 2008 Mar; 18(2):150-6.
Score: 0.133
-
Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J Vasc Interv Radiol. 2007 Sep; 18(9):1186-91.
Score: 0.128
-
Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors. Expert Rev Anticancer Ther. 2006 Dec; 6(12):1735-44.
Score: 0.122
-
Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax. AJR Am J Roentgenol. 2005 Jul; 185(1):86-8.
Score: 0.110
-
Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol. 2005 May; 16(5):679-88.
Score: 0.109
-
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy. Sci Transl Med. 2022 04 20; 14(641):eabm6420.
Score: 0.089
-
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma. Nat Commun. 2021 11 04; 12(1):6375.
Score: 0.086
-
The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. Eur Urol Oncol. 2018 10; 1(5):395-402.
Score: 0.069
-
Cryoablation of Bone Metastases from Renal Cell Carcinoma for Local Tumor Control. J Bone Joint Surg Am. 2017 Nov 15; 99(22):1916-1926.
Score: 0.065
-
Salvage surgery after energy ablation for renal masses. BJU Int. 2015 Jan; 115(1):74-80.
Score: 0.053
-
Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma. Eur Urol. 2014 Nov; 66(5):874-80.
Score: 0.050
-
Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results. BJU Int. 2013 May; 111(6):997-1005.
Score: 0.047
-
Ablative therapies in renal cell carcinoma. Minerva Urol Nefrol. 2011 Sep; 63(3):237-50.
Score: 0.042
-
Development of a research agenda for percutaneous renal tumor ablation: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol. 2010 Dec; 21(12):1807-16.
Score: 0.040
-
Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinoma. J Urol. 2010 Nov; 184(5):1882-7.
Score: 0.040
-
Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int. 2010 Feb; 105(4):496-500.
Score: 0.037
-
Patterns of intervention for renal lesions in von Hippel-Lindau disease. BJU Int. 2008 Sep; 102(8):940-5.
Score: 0.034
-
Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine? J Urol. 2003 Jul; 170(1):178-9.
Score: 0.024